A systematic review of regional hyperthermia therapy in bladder cancer

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin 2015;65:5–29.
   PubMed Web of Science ®Google Scholar
• Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013;63:234–41.
   PubMed Web of Science ®Google Scholar
• Cambier S, Sylvester RJ, Collette L, Gontero P, Brausi MA, van Andel G, et al. EORTC nomograms and risk groups for predicting recurrence, progression, and disease-specific and overall survival in non-muscle-invasive stage Ta-T1 urothelial bladder cancer patients treated with 1–3 years of maintenance bacillus Calmette–Guerin. Eur Urol 2015.
   PubMed Web of Science ®Google Scholar
• The National Comprehensive Cancer Network. Bladder Cancer, version 2.2015.
   Google Scholar
• Hall MC, Chang SS, Dalbagni G, Pruthi RS, Seigne JD, Skinner EC, et al. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 2007;178:2314–30.
   PubMed Web of Science ®Google Scholar
• Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 2003;21:1315–30.
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss EM, Rubner Y, Wunderlich R, Ott OJ, Sauer R, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia 2012;28:528–42.
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9.
   PubMed Web of Science ®Google Scholar
• Engelhardt R. Rational for clinical application of hyperthermia and drugs. Rev Med Chir Soc Med Nat Iasi 1987;91:347–52.
   PubMedGoogle Scholar
• Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, et al. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer. Urology 2004;63:466–71.
   PubMed Web of Science ®Google Scholar
• Wallner KE, Banda M, Li GC. Hyperthermic enhancement of cell killing by mitomycin C in mitomycin C-resistant Chinese hamster ovary cells. Cancer Res 1987;47:1308–12.
   PubMed Web of Science ®Google Scholar
• van der Heijden AG, Jansen CF, Verhaegh G, O'Donnell M A, Schalken JA, Witjes JA. The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines. Eur Urol 2004;46:670–4.
   PubMed Web of Science ®Google Scholar
• Colombo R, Salonia A, Leib Z, Pavone-Macaluso M, Engelstein D. Long-term outcomes of a randomized controlled trial comparing thermochemotherapy with mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU Int 2011;107:912–18.
   PubMed Web of Science ®Google Scholar
• Rigatti P, Lev A, Colombo R. Combined intravesical chemotherapy with mitomycin C and local bladder microwave-induced hyperthermia as a preoperative therapy for superficial bladder tumors. A preliminary clinical study. Eur Urol 1991;20:204–10.
   Google Scholar
• Sousa A, Inman BA, Pineiro I, Monserrat V, Perez A, Aparici V, et al. A clinical trial of neoadjuvant hyperthermic intravesical chemotherapy (HIVEC) for treating intermediate and high-risk non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:166–70.
   PubMed Web of Science ®Google Scholar
• Oliveira TR, Stauffer PR, Lee CT, Landon CD, Etienne W, Ashcraft KA, et al. Magnetic fluid hyperthermia for bladder cancer: A preclinical dosimetry study. Int J Hyperthermia 2013;29:835–44.
   PubMed Web of Science ®Google Scholar
• van der Zee J, Gonzalez Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA. Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: A prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group. Lancet 2000;355(9210):1119–25.
   PubMed Web of Science ®Google Scholar
• Lammers RJ, Witjes JA, Inman BA, Leibovitch I, Laufer M, Nativ O, et al. The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: A systematic review. Eur Urol 2011;60:81–93.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Cheng KS, Craciunescu OI, Stauffer PR, Maccarini PF, Arunachalam K, et al. Utility of treatment planning for thermochemotherapy treatment of nonmuscle invasive bladder carcinoma. Med Phys 2012;39:1170–81.
   PubMed Web of Science ®Google Scholar
• Wittlinger M, Rodel CM, Weiss C, Krause SF, Kuhn R, Fietkau R, et al. Quadrimodal treatment of high-risk T1 and T2 bladder cancer: Transurethral tumor resection followed by concurrent radiochemotherapy and regional deep hyperthermia. Radiother Oncol 2009;93:358–63.
   PubMed Web of Science ®Google Scholar
• Inman BA, Stauffer PR, Craciunescu OA, Maccarini PF, Dewhirst MW, Vujaskovic Z. A pilot clinical trial of intravesical mitomycin-C and external deep pelvic hyperthermia for non-muscle-invasive bladder cancer. Int J Hyperthermia 2014;30:171–5.
   PubMed Web of Science ®Google Scholar
• Petrovich Z, Emami B, Kapp D, Sapozink MD, Langholz B, Oleson J, et al. Regional hyperthermia in patients with recurrent genitourinary cancer. Am J Clin Oncol 1991;14:472–7.
   PubMed Web of Science ®Google Scholar
• Sapozink MD, Gibbs FA, Jr., Egger MJ, Stewart JR. Regional hyperthermia for clinically advanced deep-seated pelvic malignancy. Am J Clin Oncol 1986;9:162–9.
   PubMed Web of Science ®Google Scholar
• Juang T, Stauffer PR, Craciunescu OA, Maccarini PF, Yuan Y, Das SK, et al. Thermal dosimetry characteristics of deep regional heating of non-muscle invasive bladder cancer. Int J Hyperthermia 2014;30:176–83.
   PubMed Web of Science ®Google Scholar
• Crezee J, Van Haaren PM, Westendorp H, De Greef M, Kok HP, Wiersma J, et al. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study. Int J Hyperthermia 2009;25:581–92.
   PubMed Web of Science ®Google Scholar
• Kok HP, Ciampa S, de Kroon-Oldenhof R, Steggerda-Carvalho EJ, van Stam G, Zum Vorde Sive Vording PJ, et al. Toward online adaptive hyperthermia treatment planning: Correlation between measured and simulated specific absorption rate changes caused by phase steering in patients. Int J Radiat Oncol Biol Phys 2014;90:438–45.
   PubMed Web of Science ®Google Scholar
• Geijsen ED, de Reijke TM, Koning CC, Zum Vorde Sive Vording PJ, de la Rosette JJ, Rasch CR, et al. Combining mitomycin C and regional 70 MHz hyperthermia in patients with nonmuscle invasive bladder cancer: A pilot study. J Urol 2015;194:1202–8.
   PubMed Web of Science ®Google Scholar
• Rietbroek RC, Bakker PJ, Schilthuis MS, Postma AJ, Zum Vorde Sive Vording PJ, Gonzalez Gonzalez D, et al. Feasibility, toxicity, and preliminary results of weekly loco-regional hyperthermia and cisplatin in patients with previously irradiated recurrent cervical carcinoma or locally advanced bladder cancer. Int J Radiat Oncol Biol Phys 1996;34:887–93.
   PubMed Web of Science ®Google Scholar
• Lee CK, Song CW, Rhee JG, Foy JA, Levitt SH. Clinical experience using 8 MHz radiofrequency capacitive hyperthermia in combination with radiotherapy: Results of a phase I/II study. Int J Radiat Oncol Biol Phys 1995;32:733–45.
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Jo S, Akuta K, Nishimura Y, Nagata Y, Takahashi M, et al. Clinical results of radiofrequency capacitive hyperthermia in deep-seated tumors. Gan No Rinsho Jap J Cancer Clin 1986;32:1679–84.
   PubMedGoogle Scholar
• Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: What it is and what it isn't. 1996. Clin Orthopaed Rel Res 2007;455:3–5.
   PubMed Web of Science ®Google Scholar
• Ueda K, Sakagami H, Masui Y, Okamura T. Single instillation of hydroxypropylcellulose-doxorubicin as treatment for superficial bladder carcinoma. Cancer Chemother Pharmacol 1994;35:S81–S3.
   PubMedGoogle Scholar
• Noguchi S, Kubota Y, Miura T, Shuin T, Hosaka M. Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer. Cancer Chemother Pharmacol 1992;30:S63–S5.
   PubMed Web of Science ®Google Scholar
• Hisazumi H, Nakajima K. Eight-MHz RF hyperthermia in urological malignancies. Gan To Kagaku Ryoho Cancer Chemother 1988;15:1382–6.
   PubMedGoogle Scholar
• Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 2003;13:176–81.
   PubMed Web of Science ®Google Scholar
• Naito K, Hasegawa T, Ishida T, Yamamoto H, Mihara S, Komatsu K, et al. A clinical survey of advanced bladder cancer: Treatment of advanced and non-resectable bladder cancer. Hinyokika Kiyo Acta Urol Jap 1991;37:1601–6.
   PubMedGoogle Scholar
• Masunaga SI, Hiraoka M, Akuta K, Nishimura Y, Nagata Y, Jo S, et al. Phase I/II trial of preoperative thermoradiotherapy in the treatment of urinary bladder cancer. Int J Hyperthermia 1994;10:31–40.
   PubMed Web of Science ®Google Scholar
• Uchibayashi T, Yamamoto H, Kunimi K, Koshida K, Nakajima K. Radiofrequency capacitive hyperthermia combined with irradiation or chemotherapy for patients with invasive bladder cancers. Int Urol Nephrol 1995;27:735–41.
   PubMedGoogle Scholar
• Nishimura Y, Hiraoka M, Jo S, Akuta K, Nagata Y, Masunaga S, et al. Radiofrequency (RF) capacitive hyperthermia combined with radiotherapy in the treatment of abdominal and pelvic deep-seated tumors. Radiother Oncol 1989;16:139–49.
   PubMed Web of Science ®Google Scholar
• Ohguri T, Imada H, Nomoto S, Kato F, Yahara K, Morioka T, et al. Initial experience of bladder preservation therapy using chemoradiotherapy with regional hyperthermia for muscle-invasive bladder cancer. Thermal Med 2005;21:151–8.
   Google Scholar
• Ip S, Paulus JK, Balk EM, Dahabreh IJ, Avendano EE, Lau J. Role of Single Group Studies in Agency for Healthcare Research and Quality Comparative Effectiveness Reviews. Rockville (MD): Agency for Healthcare Research and Quality, 2013.
   Google Scholar
• Cihoric N, Tsikkinis A, van Rhoon G, Crezee H, Aebersold DM, Bodis S, et al. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry. Int J Hyperthermia 2015;31:609–14.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. PLoS Med 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097. Epub 2009 Jul 21.
   PubMed Web of Science ®Google Scholar